Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company News
A D S Diagnostic Ltd
Industry : Trading
BSE Code
ISIN Demat
Book Value(
)
523031
N.A
29.6853881
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
N.A
1.92
2.48
EPS(TTM)
Face Value(
)
Div & Yield %:
5.92
10
0
Date
Headline
11-Feb-2025
A D S Diagnostic standalone net profit declines 54.76% in the December 2024 quarter
07-Feb-2025
A D S Diagnostic Ltd - Board Meeting Outcome for Compliance As Per Regulation 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015 Outcome Of Board Meeting.
31-Jan-2025
ADS Diagnostic to conduct board meeting
16-Nov-2024
A D S Diagnostic standalone net profit declines 55.66% in the September 2024 quarter
04-Nov-2024
ADS Diagnostic schedules board meeting
26-Sep-2024
Board of ADS Diagnostic recommends final dividend
13-Sep-2024
ADS Diagnostic schedules AGM
13-Aug-2024
A D S Diagnostic standalone net profit rises 75.00% in the June 2024 quarter
13-Aug-2024
A D S Diagnostic Ltd - Board Meeting Outcome for Outcome Of The Board Meeting For The Quarter Ended June 30 2024 - SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015- Disclosure Under Regulation 30 Of The SEBI
1